Skip to content

6-KAccepted Sep 25, 4:30 PM ET

NeuroSense Therapeutics Ltd. 6-K

NRSNNeuroSense Therapeutics Ltd.

Accepted (ET)

4:30 PM

Sep 25, 2026

Filed

Sep 25, 2026

Documents

35

Size

1.9 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.